FEATURED

In Focus: Cabozantinib for RCC

Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical practice.

Previous Lymphoma Treatment, Breast Cancer Risk

Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.

Keith Flaherty, MD: Dabrafenib and Trametinib

Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.

PCa: Abiraterone and Other Hormonal Therapies

More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.

Clinicians Advocate Sexual Dysfunction After Cancer

Clinicians are advocating that sexual dysfunction after cancer, which affects a large proportion of survivors, be addressed as a serious quality of life issue.

Immune Checkpoint Inhibitors: Efficacy in Elderly

Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.

Lung Cancer: TG4010, CIMAvax-EGF Vaccine

Two vaccine therapies, TG4010 and CIMAvax-EGF, show promise for treating lung cancer.

Pembrolizumab: Mediastinal B Cell Lymphoma Tx

Pembrolizumab may be an effective treatment for patients with a rare subtype of diffuse large B-cell lymphoma, which usually carries a poor prognosis.

Fact Sheet: Cranberry and Cancer

The anticancer activity of cranberry has not yet been tested in humans, though preclinical data suggest that cranberry extract may help to treat cancer.

In ER+, early-stage breast cancer

Individualizing treatment with extended adjuvant endocrine therapy

For the treatment of metastatic non-small

Biomarker testing for epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations is important when considering a first-line therapy

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

In ER+, early-stage breast cancer

Experts discuss risk vs benefit of extended adjuvant endocrine therapy

Featured Resource

A multidisciplinary team (MDT) approach is necessary in treating metastatic breast cancer in order to provide optimal care. This article, published in JNCCN, reviews the findings of an educational needs assessment of the multidisciplinary breast cancer management team.


Latest Features

In Focus: Cabozantinib for Renal Cell Carcinoma

In Focus: Cabozantinib for Renal Cell Carcinoma

Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical practice.

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.

Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.

Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.

Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians are advocating that sexual dysfunction after cancer, which affects a large proportion of survivors, be addressed as a serious quality of life issue.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters